These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31317928)

  • 1. [Heterogeneity of tumor cells in glioblastomas].
    Nikitin PV; Ryzhova MV; Zubova IV; Panina TN; Shugay SV
    Arkh Patol; 2019; 81(3):27-36. PubMed ID: 31317928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
    Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas.
    Schröder R; Feisel KD; Ernestus RI
    J Neurooncol; 2002 Jan; 56(2):127-32. PubMed ID: 11995813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of apoptosis and proliferation in germinoma and glioblastoma.
    Mizoguchi M; Inamura T; Shono T; Ikezaki K; Inoha S; Ohgami S; Fukui M
    Neuro Oncol; 2000 Apr; 2(2):96-102. PubMed ID: 11303626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.
    Onda K; Davis RL; Wilson CB; Hoshino T
    Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material.
    Bell HS; Whittle IR; Bader SA; Wharton SB
    Neuropathol Appl Neurobiol; 2005 Apr; 31(2):191-202. PubMed ID: 15771712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
    Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR
    Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
    Schröder R; Bien K; Kott R; Meyers I; Vössing R
    Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas.
    Torp SH; Helseth E; Dalen A; Unsgaard G
    Acta Neurochir (Wien); 1992; 117(3-4):182-6. PubMed ID: 1414519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.
    Nielsen LAG; Bangsø JA; Lindahl KH; Dahlrot RH; Hjelmborg JVB; Hansen S; Kristensen BW
    Diagn Pathol; 2018 Jun; 13(1):38. PubMed ID: 29885671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis.
    Ribeiro Mde C; Coutinho LM; Hilbig A
    Arq Neuropsiquiatr; 2004 Jun; 62(2A):262-70. PubMed ID: 15235729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-3 and Bcl-2 expression in glioblastoma: an immunohistochemical study.
    Tirapelli LF; Bolini PH; Tirapelli DP; Peria FM; Becker AN; Saggioro FP; Carlotti CG
    Arq Neuropsiquiatr; 2010 Aug; 68(4):603-7. PubMed ID: 20730317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells.
    Dahlrot RH; Bangsø JA; Petersen JK; Rosager AM; Sørensen MD; Reifenberger G; Hansen S; Kristensen BW
    Sci Rep; 2021 Sep; 11(1):17918. PubMed ID: 34504133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
    Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
    Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No prognostic impact of survivin expression in glioblastoma.
    Preusser M; Gelpi E; Matej R; Marosi C; Dieckmann K; Rössler K; Budka H; Hainfellner JA
    Acta Neuropathol; 2005 May; 109(5):534-8. PubMed ID: 15843906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.
    Coons SW; Johnson PC
    J Neuropathol Exp Neurol; 1993 Nov; 52(6):609-18. PubMed ID: 8229080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.